CAR-T therapy has dramatically changed the course of cancer management over the past few years. However, despite this impact, one of the...

PD-(L)1 axis inhibits CAR-T cell activation, proliferation, survival, and functionality. Thus, CAR-T mediated direct targeting of the...

ASCO 2019 Pre-conference Read A lot has happened in the CAR-T field in the past 10 months since our last conference report on this...